1 / 7

Pharmacovigilance Market – What Factors will drive the Industry in Upcoming Years?

The study segments the Pharmacovigilance industry in light of major classification such as product type, potential markets, application, and end-user.

shabaz
Download Presentation

Pharmacovigilance Market – What Factors will drive the Industry in Upcoming Years?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market To Reach USD 11.54 Billion By 2026

  2. Market Summary Market Size – USD 4.33 Billion in 2018, Market Growth - CAGR of 13.1%, Market Trends – Product launches and research and development for advanced Pharmacovigilance According to the current analysis of Reports and Data, the global Pharmacovigilance market was valued at USD 4.33 billion in 2018 and is expected to reach USD 11.54 billion by the year 2026, at a CAGR of 13.1%. The safety concern of drug is now becoming the priority area of interest all across the world. It has opened the eyes of drug regulators as well as another regulatory body to establish a way to ensure drug safety concerns; previously, the issues were in shadow.

  3. Our Approach Our Approach Market Summary Outsourcing strategy increases the cost-effectiveness and efficiency by relieving resource pressure on firms, thereby positively supporting the market growth. Positively shifting trends in PV outsourcing owing to increasing benefits will accelerate pharmacovigilance market growth in the coming years. Major pharmaceutical industry key players are significantly involved in extensive R&D initiatives for the development of innovative therapeutic molecules to bring out the best outcomes This has successfully resulted in increased drug development activities over a period of time. Manufacturers are keenly focusing on remodeling their product development processes and work on the product portfolio and improvise the service provided by them in order to make an attempt to fulfill the unmet demand of patients across the globe. These factors are collectively anticipated to boost the pharmacovigilance market. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2253

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • According to the World Health Organization’s (WHO) report on pharmaceuticals consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital setups. Major pharmaceutical companies are involved in extensive R&D initiatives for the development of innovative therapeutic molecules. This has resulted in increased drug development activities, hence drives the market. Pharmacovigilance is vital as safety surveillance after the drug is sold to patients. It detects and reports any ADRs and harmful effects that may result in discontinuation of drugs or may be limited for the use, which created dominance with the largest market share of 36.4%. North America holds the largest revenue share of 35.7% in 2018, owing to the presence of key pharmaceutical and medical devices players, contributing to the overall revenue in this region. • • • To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report- detail/pharmacovigilance-market

  5. Our Approach Our Approach Market Summary The key players are Accenture, Clinquest Group B.V., Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc. Capgemini, ITClinical, IMD global, Foresight Group International AG, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica, Wipro Ltd., and United BioSource Corporation. For the purpose of this report, Reports and Data has segmented the market on the basis of source, product, application, and region: Clinical trial phase (Revenue, USD Million; 2016–2026) Pre-clinical Phase I Phase II Phase III Phase IV

  6. Our Approach Our Approach Market Summary Service providers (Revenue, USD Million; 2016–2026) In-house Contract Outsourcing Type (Revenue, USD Million; 2016–2026) Spontaneous Reporting Intensified ADR Reporting Targeted Spontaneous Reporting Cohort Event Monitoring EHR Mining End-Use (Revenue, USD Million; 2016–2026) Hospital Research Organization Industrial Order Now: https://www.reportsanddata.com/checkout-form/1872

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related